Moolec Science (MLEC) Payables (2022 - 2026)
Moolec Science (MLEC) reported Payables of $57.8 million for Q1 2026, up 20.25% sequentially from $48.1 million in Q4 2025.
Moolec Science (MLEC) Payables (2022 - 2026) Analysis & Trends
Moolec Science (MLEC) has 5 years of Payables data on file, last reported at $57.8 million in Q1 2026.
- For the quarter ending Q1 2026, Payables changed N/A year-over-year to $57.8 million; the trailing twelve-month figure through Mar 2026 stood at $57.8 million (changed N/A YoY), and the FY2025 full-year result was $234.5 million, down 31.73% from the prior year.
- Payables climbed to $57.8 million in Q1 2026, from $48.1 million in the prior quarter.
- In the past five years, Payables ranged from a high of $343.4 million in Q2 2024 to a low of $1.2 million in Q2 2022.
- A 5-year average of $69.5 million and a median of $7.8 million in 2023 frame the typical range for Payables.
- Across the five-year window, Payables jumped 15189.37% in 2023 and slumped 65.47% in 2024, its largest moves.
- Tracing MLEC's Payables over 5 years: stood at $8.8 million in 2022, then tumbled by 49.22% to $4.5 million in 2023, then slipped by 29.67% to $3.1 million in 2024, then surged by 1433.87% to $48.1 million in 2025, then rose by 20.25% to $57.8 million in 2026.
- Business Quant data shows MLEC's Payables at $57.8 million in Q1 2026, $48.1 million in Q4 2025, and $234.5 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,222.41 Bn | 67,222.13 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - | 10.62 Mn |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | 8.69 Mn |
| 4 | BeOne Medicines | 472.06 Bn | 467.27 Bn | 1.35 Bn | 423.55 Mn |
| 5 | Vertex Pharmaceuticals | 122.10 Bn | 114.85 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 70.00 Bn | 61.25 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.75 Bn | 50.57 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.50 Bn | 959.66 Mn | 126.63 Mn |
| 10 | Moolec Science | 5.35 Bn | 5.35 Bn | - | 57.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.80 Mn |
| Dec 31, 2025 | 48.07 Mn |
| Jun 30, 2025 | 234.48 Mn |
| Dec 31, 2024 | 3.13 Mn |
| Sep 30, 2024 | 2.68 Mn |
| Jun 30, 2024 | 343.43 Mn |
| Mar 31, 2024 | 3.28 Mn |
| Dec 31, 2023 | 4.46 Mn |
| Sep 30, 2023 | 7.76 Mn |
| Jun 30, 2023 | 187.48 Mn |
| Mar 31, 2023 | 1.38 Mn |
| Dec 31, 2022 | 8.77 Mn |
| Jun 30, 2022 | 1.23 Mn |